Back to search
Glucocorticoid Induced Osteoporosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Glucocorticoid Induced Osteoporosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Glucocorticoid Induced Osteoporosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Bone turnover markers (BTMs) are recommended as an important tool in follow-up of osteoporosis treatment. However, there is a lack of knowledge in the reliabili…
Glucocorticoids remain to be among the most important and most frequently used anti-inflammatory and immunosuppressive or immune-modulatory acting drugs to trea…
The main objective of this study is to evaluate the efficacy of Prolia® in improving bone mass density (BMD) of lumbar spine at month 12.
The investigators conducted an open-label randomized controlled trial (RCT) in chronic glucocorticoid (GC) users with moderate/high risk of fracture to compare…